Jeffrey Hall: A Pivotal Moment to Protect Rhode Island Wildlife from Anticoagulant Rodenticides
Jeffrey Hall, Executive Director at Audubon Society of Rhode Island, shared a post on LinkedIn:
“We are one vote away.
We find ourselves in a pivotal moment to protect RI wildlife from the catastrophic effects of anticoagulant rodenticides (ARs).
H7222 – critical legislation for protecting our raptors, other wildlife, and the environment – has been passed by the Senate and will now be placed on the House floor for a final vote on Wednesday, June 3rd.
Audubon has been working with both chambers of the General Assembly for the last 3 years to pass this bill.
Now they need to hear from you – their constituents!
Please reach out to your Representative ahead of Wednesday’s session and ensure that they are voting in support of H7222.
With the passage of this legislation, Rhode Island can lead by example on stronger wildlife protections and effective rodent management.
Find your representative here.
For more information on this bill.
Please join us in making one more push to get this legislation across the finish line!”
Stay updated with Hemosatsis Today.
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome